MedTrace Logo

Human Papillomavirus Screening and Vaccine Readiness Program

NCT00863096 · Status: WITHDRAWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2011-03-03

No results posted yet for this study

Summary

Public Health Research Institute (PHRI) is carrying out a 15 month research and advocacy project with the goals of generating critical data on acceptability, identifying determinants and facilitators of HPV vaccine uptake in adolescent girls; and investigating physicians' attitudes to identify predictors of intention to recommend immunization in Mysore, India.

Conditions

  • Human Papilloma Virus-Related Carcinoma

Interventions

BIOLOGICAL

Gardasil

HPV vaccine

Sponsors & Collaborators

  • PATH

    collaborator OTHER

  • Public Health Research Institute, India

    lead OTHER

Principal Investigators

  • Purnima Madhivanan Madhivanan, MD, PhD · Public Health Research Institute, India

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-06-30
Completion
2010-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00863096 on ClinicalTrials.gov